"Neuraminidase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992)
Descriptor ID |
D009439
|
MeSH Number(s) |
D08.811.277.450.692
|
Concept/Terms |
Neuraminidase- Neuraminidase
- Exo-alpha-Sialidase
- Exo alpha Sialidase
- Sialidase
- N-Acylneuraminate Glycohydrolases
- Glycohydrolases, N-Acylneuraminate
- N Acylneuraminate Glycohydrolases
- Oligosaccharide Sialidase
- Sialidase, Oligosaccharide
|
Below are MeSH descriptors whose meaning is more general than "Neuraminidase".
Below are MeSH descriptors whose meaning is more specific than "Neuraminidase".
This graph shows the total number of publications written about "Neuraminidase" by people in this website by year, and whether "Neuraminidase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 0 | 1 | 1 |
2018 | 0 | 1 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neuraminidase" by people in Profiles.
-
Differential glycosylation of tissue non-specific alkaline phosphatase in mesenchymal stromal cells differentiated into either an osteoblastic or adipocytic phenotype. Exp Cell Res. 2022 12 01; 421(1):113372.
-
Replacement of neuraminidase inhibitor-susceptible influenza A(H1N1) with resistant phenotype in 2008 and circulation of susceptible influenza A and B viruses during 2009-2013, South Africa. Influenza Other Respir Viruses. 2019 01; 13(1):54-63.
-
Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res. 2009 Jul; 83(1):90-3.